moneyheap
A · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is Agilent Technologies Inc. (A) stock moving?
Agilent closed at $177.88 on Nov 10, up about 2.3% from $173.89 on Oct 22, so the stock has been roughly flat over the last month. It traded between $171.78 and $182.99, with the high on Oct 28 and the low on Nov 5. Volume has mostly run near 2.1M shares a day, with heavier sessions on Oct 30 (2.76M, down 3.5%) and Nov 5 (2.70M, down 1.7%) as the stock fell. It then rebounded to $180.17 on Nov 9 before easing back. Recent company news is mixed to constructive: the completed $240M cash acquisition of Proscia adds digital pathology software, a new mass spectrometry detector launched Nov 2, and the company's 10-year return has beaten the market by 1.1% a year. Against this, Evercore ISI cut its price target to $172 from $178 on Oct 28, which sits below the current price. The next major catalyst is the Q4 FY2026 results on Nov 23, and no SEC filings were found in the last 45 days, so the outlook for the next few weeks depends largely on that report.
News behind the analysis
- Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 YearsAgilent has outperformed the market over the past 10 years by 1.1% annualized, with an average annual return of 14.24%.
- Agilent Technologies Completes Acquisition of ProsciaAgilent finalized its purchase of Proscia, a digital pathology software provider, for $240 million in cash plus potential performance-based earn-outs.
- Agilent Technologies Launches 5987A Single Quadrupole Mass Selective DetectorAgilent introduced the 5987A single quadrupole mass selective detector with GC Assist and MassHunter 14 software to improve laboratory efficiency and data quality.
- Agilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23Agilent scheduled the release of its fourth-quarter fiscal 2026 results for November 23, 2026, which is the next major company event.
- Evercore ISI Adjusts Price Target on Agilent TechnologiesEvercore ISI lowered its price target on Agilent from $178 to $172, while the stock closed at $177.88 on Nov 10.
About Agilent Technologies Inc.
Agilent Technologies makes lab instruments, software, consumables and services used to analyze chemicals, drugs, food, environmental samples and patient tissue. It was spun off from Hewlett-Packard in 1999 and is known for its chromatography and mass spectrometry equipment. A large share of its revenue comes back every year through consumables and service contracts.
How it makes money
Agilent reports three segments. Using fiscal Q3 2026 figures, the Agilent CrossLab Group (consumables, service contracts, software and lab support) brought in about 42% of revenue. The Life Sciences and Diagnostics Markets Group (liquid chromatography, mass spectrometry, cell analysis, pathology and companion diagnostics) brought in about 40%. Applied Markets (instruments for chemicals, advanced materials, food, environmental and forensics testing) brought in about 18%. Total revenue for fiscal 2026 is guided at roughly $7.5 billion.
What usually moves A
- Pharma and biotech lab spending, including GLP-1 and other drug manufacturing
- Instrument replacement cycles and capital spending
- Academic and government funding, including China demand
- Chemical and semiconductor industry activity
- Tariffs, currency moves and acquisitions such as Biocare